1. Activation of Piezo1 increases the sensitivity of breast cancer to hyperthermia therapy
- Author
-
Wang Shao-kang, Zhang Xiao-ting, Jiang Xuan-yao, Geng Bi-jiang, Qing Tao-lin, Li Lei, Chen Yun, Li Jin-feng, Zhang Xiao-fang, Xu Shuo-gui, Zhu Jiang-bo, Zhu Yu-ping, Wang Mei-tang, and Chen Ji-kuai
- Subjects
photothermal therapy ,heat stress ,piezo1 ,breast cancer ,Medicine - Abstract
Photothermal therapy (PTT) of nanomaterials is an emerging novel therapeutic strategy for breast cancer. However, there exists an urgent need for appropriate strategies to enhance the antitumor efficacy of PTT and minimize damage to surrounding normal tissues. Piezo1 might be a promising novel photothermal therapeutic target for breast cancer. This study aims to explore the potential role of Piezo1 activation in the hyperthermia therapy of breast cancer cells and investigate the underlying mechanisms. Results showed that the specific agonist of Piezo1 ion channel (Yoda1) aggravated the cell death of breast cancer cells triggered by heat stress in vitro. Reactive oxygen species (ROS) production was significantly increased following heat stress, and Yoda1 exacerbated the rise in ROS release. GSK2795039, an inhibitor of NADPH oxidase 2 (NOX2), reversed the Yoda1-mediated aggravation of cellular injury and ROS generation after heat stress. The in vivo experiments demonstrate the well photothermal conversion efficiency of TiCN under the 1,064 nm laser irradiation, and Yoda1 increases the sensitivity of breast tumors to PTT in the presence of TiCN. Our study reveals that Piezo1 activation might serve as a photothermal sensitizer for PTT, which may develop as a promising therapeutic strategy for breast cancer.
- Published
- 2024
- Full Text
- View/download PDF